3D Bioprinting Solutions, based in Russia, has announced that they have followed through on their promise and have announced that they have produced the world’s first 3D printed transplantable organ, a thyroid gland which will be used on a mouse.
Cellink produces and sells a hydrogel that is compatible with all extrusion based 3D bioprinters. Basically want to establish themselves as the leading suppliers of consumables as bioprinters become more widely available and their prices drop.
In Organovo's financial conference call today, Keith Murphy, Organovo’s chief executive officer, indicated that “response to the exVive3D Human Liver Tissue has been strong, and in line with our expectations. We continue to expect this tissue to grow into the tens of millions in annual revenue, and that it has $100M+ revenue potential.
NecropSynth announced that they are beginning production of 3d designed and printed, macroscopically accurate, anatomical models for scientific and education purposes with the ultimate goal being to reduce the number of animals sacrificed in biological testing.
In a new research report, detailed in the Journal of Advanced Materials, researchers have discovered a way of creating hydrogels that are “extremely tough and robust”, while also being compatible with the encapsulation of cells within the structure itself.
In recognition of the huge potential of bioactive 3D printing, Louisiana State University Health Sciences Center at Shreveport has recently been awarded a $40,000 grant/investment to open the first Shreveport, LA area medical 3D printing lab.
BASF and Poietis, the first company in the world for 3D laser-assisted bioprinting, have signed an agreement on research and development in cosmetics. Based on the combined expertise of both companies in tissue engineering and bioprinting, the agreement aims to apply the bioprinting technology of Poietis to improve BASF’s skin equivalent model Mimeskin™.
3D bioprinting startup BioBots has just surpassed the $300k mark on their FundersClub campaign.
Rokit, a South Korean 3D printer manufacturer announced a $3 million government grant for the development of bioprinting technology.
ElectroMaterials researcher Cathal O'Connell believes that while hollow organs, such as the bladder, were printed a decade ago, printing ‘solid organs’, such as the kidney or the liver, are still probably a couple of decades into the future.
Kyushu University was awareded a patent for “Method for production of three-dimensional structure of cells.”
Cyfuse Biomedical and Cyberdyne signed a $12 million deal to develop and market the Regenova 3D tissue printing system.
A popular Mechanics article interview Wake Forest University team about their plans to 3d print using lab-grown heart cells.
Israeli company, Nano dimension has proposed use of stem cells in 3-D bioprinters which will be groundbreaking to medical world. The whole project is in partnership with stem cell research company Accellta.
Researchers at Drexel university of Philadelphia and Tsinghua University of Beijing are claiming that using embryonic stem cells combined with hydrogel scaffolds, they can finally print micro-organs. These micro-organs can be anything from brain tissue, heart cells or bone.
Researchers at Lawrence Livermore,California , have successfully 3D printed live blood vessels from cells and organic material. These vessels are capable of self-assembling and delivering nutrients, but are being worked on for further organization before they can be used in real transplants.
Sweden Team led by Paul Gatenholm at the Wallenberg Wood Science Center has discovered scaffolds to regenerate Cartilages using 3D printed technology. These 3D printed chondrocytes when implanted in living mice, resulted in cartilage production. The team is currently working to explore it's use in human clinical trials.
Australian Society of Medical Research will present latest diabetes treatment developments at SAHMRI, Adelaide. The researchers will be presenting replacement for insulin producing cells, and some further set of developments.
The MESO-BRAIN consortium received €3.3 million funding from European Commision under its Future and Emerging Technology (FET) funding program. Meso-Brain is currently planning to support the development of human neural networks that emulate brain activity using human induced pluripotent stem cells differentiated into neurons.
Pluripotent cells are creators of almost every mature cell in body, including the keratinocytes and melanocytes of skin. Reprogramming these mature cells to obtain pluripotent cells, and ultimately using them to produce living tissue using living tissue, this can make Facial implants possible.
Nano Dimesnion has announced that it has filed patent application too U.S Patent and Trademark Office for the 3D printing of stem cells. The patent discloses it will be using MRI and CT scans to print biological structure of the tissue or organ using 3D bioprinter and bioink materials. The patent came after concept of 3D printing stem cells weeks back.
Amedica Corporation, a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, has announced its product- Robocasting. Robocasting is a freeform fabrication technique for dense ceramics, sinters within 24 hours while also allows custom fabrication of bone scaffolds suited for cellular differentiation and neovascularization.
Amy Karle, from Artist in Residence at Autodesk has used CAD design and 3D Printing to create scaffolds in support of cell growth into certain forms by which 3D Printed framework for tissue generation can be made. She makes her own 3D Printed material using polyethylene (glycol) diacrylate (PEGDA) hydrogel and 3D Printing it by Ember 3D Printer.
8485 E McDonald Dr #550Scottsdale, AZ 85250
Phone 480.755.1155
Fax: 480-247-4213